ONCS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Jun 2023 @ 22:00):

Stats
Tagesvolumen	51.30M
Durchschnittsvolumen	2.13M
Marktkapitalisierung	1.65M
EPS	$-2.65 ( Q2 \| 2023-03-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0136 (Sector) 42.63 (Industry) 24.32
ATR14	$0.108 (38.96%)

AADI -2.86%

ABCL -2.15%

ABCM 0.04%

ABEO -2.99%

ABIO 2.29%

ABOS -4.46%

ABSI -3.29%

ABUS -0.65%

ABVX -3.34%

ACAD -1.76%

ACER -17.95%

ACET -2.00%

ACGN 1.29%

ACHL 1.43%

ACHV -1.90%

ACIU -3.37%

ACLX -4.07%

ACRV -3.19%

ACST -3.13%

ACXP -4.82%

ADAG -3.08%

ADAP -1.67%

ADGI 0.87%

ADIL -0.87%

ADMA 0.00%

ADPT 3.04%

ADTX 1.13%

ADVM 1.02%

ADXN -1.60%

AEON 5.94%

AEZS 0.22%

AFMD -3.54%

AGEN -2.36%

AGIO -1.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.20%

AKRO -1.47%

AKTX -25.54%

AKUS 0.00%

ALBO 0.00%

ALDX 1.22%

ALEC -5.01%

ALGS -6.06%

ALKS -1.83%

ALLK -1.67%

ALLO -8.05%

ALLR -34.80%

ALNA 3.16%

ALNY 7.74%

ALPN 0.02%

ALPX 0.00%

ALRN -1.64%

ALT 3.78%

ALVR -1.01%

ALXN 0.00%

ALXO 0.31%

ALZN -2.08%

AMRN 2.72%

AMTI -3.13%

ANAB -0.83%

ANEB 4.87%

ANGN 0.00%

ANIX -1.20%

ANL -3.22%

ANNX -3.98%

ANPC -3.15%

APGE -3.92%

APGN 8.48%

APGNW 30.65%

APLM -3.77%

APLS 5.15%

APLT -4.10%

APM 1.06%

APOP 0.38%

APRE 0.24%

APTO -1.43%

APTX 3.17%

APVO -6.12%

ARAV -13.39%

ARCT -3.88%

ARDS 2.28%

ARDX -3.68%

ARGX 2.49%

ARNA 0.00%

ARPO -0.90%

ARQT 8.11%

ARTL 11.29%

ARTLW 0.00%

ARVN -2.04%

ARWR -1.36%

ASLN -2.08%

ASMB -1.91%

ASND 4.95%

ATAI -3.57%

ATHA -7.59%

ATHE -0.83%

ATHX -33.50%

ATNF -0.66%

ATOS -3.74%

ATRA -6.10%

ATXI -2.72%

ATXS -1.74%

AUPH -1.59%

AURA -4.22%

AUTL -6.45%

AVBP -2.13%

AVEO 0.00%

AVIR -1.72%

AVRO -1.41%

AVTE -3.33%

AVTX 3.46%

AVXL -3.80%

AXLA 0.00%

AXSM 0.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -1.92%

BCDA 3.53%

BCDAW -39.75%

BCEL 0.00%

BCLI 3.13%

BCRX -3.03%

BCTX -13.88%

BCTXW -4.44%

BCYC -2.58%

BDRX -2.01%

BDTX -3.89%

BEAM -2.34%

BFRA -2.91%

BGNE -5.13%

BIOR -2.10%

BIVI -5.32%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -5.71%

BLTE -0.27%

BLU 0.03%

BLUE -7.08%

BMEA -6.13%

BMRN -0.20%

BNOX -9.25%

BNTC 0.00%

BNTX -2.57%

BOLD -18.11%

BOLT 0.18%

BPMC 0.42%

BPTH 0.48%

BPTS -13.47%

BRNS 0.74%

BRTX 2.91%

BTAI -0.84%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -5.22%

CABA -13.47%

CADL -8.13%

CALA 0.00%

CALC 0.00%

CALT -1.18%

CAPR -3.13%

CARA -2.56%

CARM 2.68%

CASI -4.74%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.86%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -8.01%

CDIOW 24.00%

CDMO -1.53%

CDMOP 0.04%

CDT -15.17%

CDTTW -39.60%

CDTX 5.75%

CDXC -4.31%

CDXS -3.33%

CELC -1.02%

CELU -2.60%

CELUW 11.80%

CERC -1.68%

CERE -4.49%

CERO -14.81%

CEROW 0.60%

CFRX -27.95%

CGEM -5.47%

CGEN -3.21%

CGON -1.47%

CGTX -4.86%

CHMA -6.00%

CHRS -3.07%

CINC 0.00%

CING -3.46%

CINGW 34.95%

CKPT 0.48%

CLBS -16.75%

CLDX 0.11%

CLGN 0.59%

CLLS 1.05%

CLNN -5.91%

CLNNW 0.00%

CLRB -5.59%

CLSD 15.74%

CLSN -0.68%

CLVS 0.00%

CMMB 2.45%

CMND -7.46%

CMPI 0.00%

CMPX -4.50%

CMRA 0.00%

CMRAW 33.33%

CMRX 2.05%

CNCE 0.00%

CNSP 27.35%

CNST 0.00%

CNTA 0.00%

CNTB -3.62%

CNTX 0.46%

COCP -7.20%

COEPW 32.45%

COGT -6.41%

CORT -0.65%

COYA 4.24%

CPRX -1.56%

CRBP 1.93%

CRBU -5.88%

CRDF -4.24%

CRGX -4.30%

CRIS -4.39%

CRNX -1.73%

CRSP -3.43%

CRTX 2.63%

CRVO 0.00%

CRVS -2.73%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -9.02%

CTNM 3.86%

CTXR 5.10%

CUE -1.70%

CVAC 2.02%

CVKD -2.39%

CWBR 2.80%

CYAD -12.96%

CYCC -4.79%

CYCCP 5.49%

CYCN 5.02%

CYT -2.27%

CYTK -1.91%

CYTO -6.78%

DARE -2.35%

DAWN -0.96%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 1.80%

DNLI -2.27%

DNTH -5.02%

DOMH 2.16%

DRMA -6.21%

DRMAW -1.25%

DRNA 0.00%

DRTS -1.82%

DRTSW 0.00%

DRUG 5.61%

DSGN -1.49%

DTIL 0.95%

DYAI -3.13%

EARS -1.77%

EDIT -2.17%

EDSA -3.71%

EFTR -1.06%

EFTRW 145.45%

EIGR -9.21%

ELAB -1.03%

ELDN -8.81%

ELEV -1.63%

ELOX -7.14%

ELTX -4.76%

ELVN -1.69%

ELYM -5.28%

ENGN -0.37%

ENGNW 18.81%

ENLV -3.55%

ENOB 1.79%

ENSC -3.98%

ENTA 0.25%

ENTO 1.69%

ENTX -9.22%

ENVB -7.29%

EPIX 0.00%

EPRX -2.97%

EPZM 0.00%

EQ 0.46%

EQRX -2.09%

EQRXW 0.00%

ERAS -3.70%

ERNA -1.64%

ERYP 1.30%

ESLA -0.65%

ESLAW 87.05%

ETNB -6.98%

ETON -1.20%

ETTX 0.00%

EVAX 6.44%

EVGN 0.58%

EVLO 0.00%

EWTX 4.07%

EXAI 0.95%

EXEL -0.27%

EYEG 0.04%

EYEN -2.23%

EYPT -3.05%

FATE -3.13%

FBIO -0.59%

FBIOP 0.32%

FBLG 0.00%

FBRX -6.12%

FDMT -5.38%

FENC -2.36%

FGEN -2.50%

FHTX -1.50%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.30%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -2.26%

FULC -5.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 4.69%

GANX 0.78%

GBIO 1.43%

GBT 0.01%

GDTC -1.45%

GERN -1.53%

GHRS 0.84%

GLMD -2.79%

GLPG -2.10%

GLSI -0.77%

GLTO -6.44%

GLUE -0.52%

GLYC 25.28%

GMAB -0.15%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.81%

GNLX -0.88%

GNPX 0.99%

GNTA 3.94%

GOSS 22.26%

GOVX -27.39%

GOVXW -49.04%

GPCR -8.52%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.41%

GRTX 12.03%

GTHX -0.90%

GUTS -9.22%

GXGXW 41.67%

GYRE -3.78%

HALO 0.65%

HARP 0.09%

HCWB -1.65%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -2.68%

HOOK 0.30%

HOTH -4.46%

HOWL -10.34%

HRMY -0.07%

HRTX -4.09%

HSTO 0.00%

HUMA -3.33%

HUMAW 1.27%

IBRX -0.95%

ICCC 0.22%

ICPT 0.21%

ICU -19.90%

ICUCW -13.76%

ICVX -0.91%

IDRA -23.04%

IDYA -2.38%

IFRX -2.99%

IGMS -6.44%

IKNA 0.00%

IKT 0.40%

IMAB 0.00%

IMCR -1.09%

IMGN 0.02%

IMGO 0.00%

IMMP -1.13%

IMMX 1.75%

IMNM -3.35%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -4.03%

IMTX -1.64%

IMTXW 6.00%

IMUX -1.82%

IMV 0.00%

IMVT -0.29%

INAB 1.54%

INBX -2.46%

INCY -1.02%

INDP -1.80%

INFI -52.38%

INKT -1.11%

INM -6.35%

INMB -5.05%

INO -3.39%

INSM 1.87%

INTS 0.20%

INVA 0.88%

INZY -2.46%

IOBT 6.72%

IONS 5.19%

IOVA 3.55%

IPA 0.00%

IPHA -1.72%

IPSC -4.48%

IRON -1.04%

ISEE 0.38%

ITOS -1.81%

ITRM 3.42%

IVA 6.96%

IVVD -4.72%

JAGX 0.53%

JANX -4.05%

JAZZ -1.59%

JNCE 0.00%

JSPR -5.33%

JSPRW -16.18%

JUNS 0.00%

JUNSW 0.00%

KA -13.66%

KALV -1.45%

KDNY 0.22%

KMPH -0.34%

KNSA 0.53%

KNTE -0.38%

KOD -7.33%

KPRX 2.21%

KPTI -0.91%

KRBP -10.00%

KRON -6.43%

KROS -1.79%

KRRO -4.81%

KRTX 0.03%

KRYS 1.37%

KTRA 13.76%

KTTA 8.16%

KTTAW 0.92%

KURA -2.80%

KYMR -0.95%

KYTX -1.90%

KZIA -12.30%

KZR 0.97%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.00%

LENZ -2.43%

LEXX -2.26%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -2.08%

LIAN -8.28%

LIFE 2.70%

LIPO -23.38%

LIXT 0.77%

LIXTW -42.57%

LJPC -0.32%

LMNL 0.12%

LOGC 2.68%

LPCN -12.37%

LPTX -3.19%

LQDA -2.54%

LRMR -3.50%

LSTA 3.21%

LTRN 2.56%

LUMO -1.32%

LVTX 3.19%

LXEO -0.76%

LXRX -6.08%

LYEL -3.77%

LYRA -1.79%

MACK 0.10%

MBIO -12.31%

MBRX -0.71%

MCRB -1.11%

MDGL -1.39%

MDNA -13.16%

MDWD 0.55%

MDXG -0.15%

MEIP 2.88%

MESO -0.59%

MGNX -4.67%

MGTA -7.74%

MGTX -1.17%

MGX 3.61%

MIRM -4.91%

MIRO 0.59%

MIST -7.19%

MITO 0.00%

MLEC 7.41%

MLECW 23.81%

MLND -5.36%

MLTX 2.56%

MLYS -3.64%

MNKD -3.50%

MNMD -4.20%

MNOV 2.16%

MNPR 2.63%

MOLN 0.97%

MOR -1.71%

MORF 6.79%

MREO -6.91%

MRKR -1.49%

MRNA 0.44%

MRNS -0.73%

MRSN -4.98%

MRTX -0.17%

MRUS -0.23%

MRVI -2.83%

MTCR -1.29%

MTEM -2.88%

MTP -18.50%

MURA 0.31%

MYMD -1.60%

NAMS 0.20%

NAMSW 0.43%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 11.93%

NCNA -5.00%

NERV -2.15%

NEXI -1.06%

NGM -1.28%

NGNE -2.05%

NKGN 0.00%

NKGNW 8.00%

NKTR -8.55%

NKTX 9.46%

NLSP -7.12%

NLSPW 26.67%

NMRA -7.89%

NMTR -42.97%

NOVN -24.84%

NRBO 4.41%

NRIX -1.09%

NRSN 1.06%

NRSNW 0.00%

NRXP 0.75%

NRXPW 27.78%

NRXS -2.73%

NTBL -11.13%

NTEC -12.45%

NTHI 0.00%

NTLA -4.00%

NTRBW -31.07%

NUVL -0.30%

NVAX -0.14%

NVCT -1.39%

NVIV -34.28%

NXTC 1.19%

NYMX -0.05%

OABI -6.65%

OABIW -10.06%

OBIO -0.58%

OBSV 0.00%

OCEA 2.16%

OCGN -6.35%

OCS -0.30%

OCUL 0.46%

OCUP -4.38%

ODT -4.27%

OKYO -4.13%

OLMA -1.26%

OMER -4.77%

OMGA -0.83%

ONCO -2.22%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO -5.06%

OPNT 0.00%

OPT -1.03%

ORGS -1.66%

ORIC -5.73%

ORMP 0.45%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.10%

OVID -11.39%

OYST 0.00%

PALI -3.25%

PASG 0.22%

PBLA 0.00%

PBM -4.22%

PBYI 1.37%

PCSA 6.92%

PCVX -1.69%

PDSB 10.49%

PEPG -6.00%

PGEN 3.73%

PHAR -6.99%

PHAS 0.00%

PHAT -4.62%

PHIO 2.30%

PHIOW 36.47%

PHVS 7.54%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.79%

PLUR -5.45%

PMN -5.66%

PMVP -0.59%

PNT 0.16%

PPBT -7.68%

PRAX -6.28%

PRDS 0.93%

PRLD -3.56%

PROG -3.47%

PROK -3.46%

PRQR 0.61%

PRTA -3.84%

PRTC -0.08%

PRTG -5.03%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 1.86%

PSTX -6.18%

PTCT -1.73%

PTE -0.82%

PTGX -0.94%

PTIXW -5.10%

PULM 2.63%

PXMD -4.59%

PYPD 0.07%

PYXS -4.08%

QLGN -6.58%

QNCX -2.48%

QNRX -4.84%

QSI -2.50%

QSIAW -3.13%

QTTB -3.97%

QURE -1.76%

RAIN -1.63%

RANI -9.00%

RAPT -4.94%

RARE 1.09%

RCKT -0.87%

REGN 0.69%

RENB 1.26%

REPL 0.68%

RETA 0.02%

REUN -0.89%

REVB -10.42%

REVBU 3.46%

REVBW -38.46%

RGLS 4.39%

RGNX -3.67%

RIGL -11.87%

RLAY -2.32%

RLMD -0.33%

RLYB -3.25%

RNA -1.79%

RNAC 4.43%

RNAZ 1.96%

RNXT -1.74%

ROIV -0.73%

ROIVW 4.56%

RPHM -0.62%

RPRX -0.77%

RPTX -3.67%

RUBY 2.70%

RVLP -32.05%

RVMD 0.86%

RVMDW 5.10%

RVNC -8.56%

RVPH -1.56%

RVPHW -3.43%

RXDX 0.09%

RXRX 0.43%

RYTM 0.52%

RYZB 0.02%

RZLT -9.15%

SABS 0.00%

SABSW 0.25%

SAGE -5.71%

SANA -2.17%

SAVA -2.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.04%

SCPH -2.94%

SCPS 0.00%

SEEL 2.13%

SEER -1.73%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.94%

SGMT -1.43%

SGTX -2.56%

SIOX 22.63%

SLDB -12.39%

SLGL 8.36%

SLN -2.01%

SLNO -2.84%

SLRX 1.24%

SLS -3.31%

SMMT 0.13%

SNDX -1.31%

SNGX -21.60%

SNPX -3.13%

SONN -0.33%

SPPI -0.49%

SPRB 3.68%

SPRC -2.37%

SPRO 0.00%

SRNE -9.09%

SRPT -3.53%

SRRA 0.00%

SRRK -4.04%

SRZN -2.45%

STAB 0.00%

STOK -2.65%

STRO -2.61%

STSA 0.00%

STTK -10.11%

SURF -0.93%

SVRA 3.83%

SWTX 0.94%

SYBX 1.97%

SYRS -0.17%

TALS -0.73%

TARA -5.83%

TARS -2.36%

TBPH -4.22%

TCBP -9.85%

TCDA 0.00%

TCON 21.14%

TCRR 0.00%

TCRT -3.63%

TCRX -7.47%

TECH -1.91%

TENX 3.88%

TERN -3.59%

TFFP 3.68%

TGTX 4.24%

THRX 0.12%

TIL 0.00%

TLC 0.00%

TLSA 2.32%

TNGX -8.77%

TNXP 5.04%

TNYA -7.61%

TPST -1.44%

TRDA 3.72%

TRVI -1.14%

TRVN -2.41%

TSHA -7.33%

TSVT -2.59%

TTNP -0.91%

TVTX 2.18%

TYRA -0.88%

UBX 0.36%

UNCY -26.76%

URGN -5.61%

UTHR 0.03%

VACC 11.36%

VALN -4.35%

VAXX -5.88%

VBIV 3.23%

VBLT -8.77%

VCEL -2.81%

VCNX -6.47%

VCYT -0.92%

VERA 0.97%

VERU -6.67%

VERV -0.95%

VIGL -4.12%

VINC -3.01%

VIR 0.66%

VIRI -5.96%

VIRX -3.22%

VKTX -8.29%

VLON -13.04%

VNDA 2.68%

VOR 0.00%

VRCA -0.98%

VRDN -3.41%

VRNA -4.14%

VRPX -2.58%

VRTX -0.24%

VSTM -5.16%

VTGN 2.79%

VTVT -6.43%

VTYX -4.02%

VXRT -7.63%

VYGR -2.92%

VYNE 0.00%

VYNT 7.78%

WINT -3.24%

WVE -8.45%

XBIO -8.15%

XBIT 5.73%

XCUR -4.08%

XENE -1.10%

XERS -0.47%

XFOR -4.95%

XLO -3.30%

XLRN 0.00%

XNCR -3.68%

XOMA -5.07%

XOMAO 0.36%

XOMAP 0.73%

XRTX -3.29%

YMAB 1.16%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.23%

ZNTL -8.70%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-02-09	Delaversano Robert J	Sell	40	Common Stock
2022-11-04	Delaversano Robert J	Sell	283	Common Stock
2022-10-07	Foster Spahr Stephany	Buy	50 000	Stock Option (right to buy)
2022-10-07	Foster Spahr Stephany	Buy	0
2022-08-05	Delaversano Robert J	Sell	284	Common Stock

INSIDER POWER
97.76
Last 87 transactions
Buy: 13 356 389 \| Sell: 519 303

Volumen Korrelation

Lang: 0.07 (neutral)

Kurz: 0.93 (very strong)

Signal:(31.668) Expect same movement, but be aware

OncoSec Medical Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

OncoSec Medical Inc Korrelation - Währung/Rohstoff

-0.53
( weak negative )

0.06
( neutral )

-0.77
( moderate negative )

-0.51
( weak negative )

0.23
( neutral )

0.86
( strong )

OncoSec Medical Inc Finanzdaten

Annual	2022
Umsatz:	$0
Bruttogewinn:	$0 (0.00 %)
EPS:	$-19.13

FY	2022
Umsatz:	$0
Bruttogewinn:	$0 (0.00 %)
EPS:	$-19.13

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-30.20

FY	2020
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-56.22

Financial Reports:

No articles found.

OncoSec Medical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OncoSec Medical Inc

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.